TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.

R K Ramanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.